跳至主要内容
临床试验/CTRI/2014/09/005048
CTRI/2014/09/005048尚未招募2 期

CLINICAL EVALUATION OF GOKSHURADI GUGGULU AND GUDUCHI CHURNA IN THE MANAGEMENT OF TYPE II DIABETES MELLITUS (MADHUMEHA) - CEGGMDM

Central Council for Research in Ayurvedic sciences CCRAS0 个研究点目标入组 58 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Diabetics aged between 30 to 60 years.
  • 2.The freshly diagnosed and naive (those who are not taking any Oral Hypoglycaemic Agent.)
  • 3. Patients who are diagnosed to be Type 2 Diabetics by either having Glycosylated haemoglobin (HbA1c) >= 6.5% or BS-F > 126 mg% or BS-PP >200 mg%.
  • 4.Willing to participate.

排除标准

  • 1.Patients already diagnosed to be suffering from the complications of Diabetes Mellitus viz., diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, etc.
  • 2. Patients suffering from Type I Diabetes Mellitus or Brittle Diabetes Mellitus.
  • 3.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
  • 4.Hypertensive patients ( > 140 / 90 mm Hg).
  • 5.Patients with poorly controlled Glycaemic status (HbA1c >8%).
  • 6.Symptomatic patient with clinical evidence of Heart failure.
  • 7.Patients with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT > 3 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2 mg/dl),uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or other concurrent severe disease.
  • 8.Pregnant / Lactating women.
  • 9.Patient on steroids, oral contraceptive pills or estrogens replacement therapy.
  • 10.Alcoholics and/or drug abusers.
  • 11.Patients with evidence of malignancy
  • 12.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, etc.)
  • 13.H/o hypersensitivity to any of the trial drugs or their ingredients.
  • 14.Patients who have completed participation in any other clinical trial during the past six (06) months
  • 15.Patients with Microvascular and other complications of Diabetes Mellitus.
  • 16..The patients suffering from Brittle Diabetes.
  • 17.Any other condition which the Investigator thinks may jeopardize the study.

研究者

发起方
Central Council for Research in Ayurvedic sciences CCRAS

相似试验